1.5.2007
News

International agreement to eliminate customs duties on approved pharmaceuticals

EU Member States adopted an international agreement to eliminate customs dutieson all new pharmaceuticals traded with the US and Switzerland. The agreement wasreached on 12 January 2007 and eliminates customs duties between the EU,Switzerland and US on finished pharmaceutical products and on the chemicalintermediates used in their production. It replaces a previous agreement from1994 that already enabled many pharmaceuticals to benefit from zero-tariffs, butdid not cover any of the more recent products. With this review, 1,290additional products have been added to the 7,329 products currently benefitingfrom duty-free treatment. The EU imports more than 80% of its pharmaceuticalsfrom the US and Switzerland, and the European Chemical Industry Council (CEFIC)believes that the agreement could save European pharmaceutical companies up to€230 million in 2007 alone.

Other articles

2.6.2026
News

KŠB once again assists with ČEZ’s General Meeting

The KŠB team, consisting of Jana Guričová, Martin Kubík and Jan Lasák, led by Petr Kasík, provided legal support to ČEZ in connection with the preparation and conduct of its General Meeting.

The KŠB team, consisting of Jana Guričová, Martin Kubík and Jan Lasák, led by Petr Kasík, provided legal support to ČEZ in connection with the preparation and conduct of its Annual General Meeting.

2.6.2026
News

DNS – What Now Constitutes a Commonly Available Supply or Service

Professional literature has traditionally compared a dynamic purchasing system (DNS) to a standard online purchase. However, in its judgment No. 22 As 15/2025-65 of 12 May 2026, the Supreme Administrative Court significantly refined this understanding.

Professional literature has traditionally compared a dynamic purchasing system (DNS) to a standard online purchase. However, in its judgment No. 22 As 15/2025-65 of 12 May 2026, the Supreme Administrative Court significantly refined this understanding.

28.5.2026
Capital markets

KŠB Advised J&T IB and Capital Markets on the 3M FUND MSI SICAV Bond Program

Kocián Šolc Balaštík provided legal advice to J&T IB and Capital Markets, a.s. as the arranger in preparing the base prospectus for 3M FUND MSI SICAV a.s.’s bond program.

Kocián Šolc Balaštík provided legal advice to J&T IB and Capital Markets, a.s. as the arranger in preparing the base prospectus for 3M FUND MSI SICAV a.s.’s bond program.